Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-10-184932
Filing Date
2010-08-10
Accepted
2010-08-10 17:09:14
Documents
5
Period of Report
2010-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 818575
2 SECOND AMENDED AND RESTATED COLLABORATION AGREEMENT, DATED APRIL 20, 2010 dex101.htm EX-10.1 196653
3 CERTIFICATION OF CHIEF EXECUTIVE OFFICER dex311.htm EX-31.1 6369
4 CERTIFICATION OF CHIEF FINANCIAL OFFICER dex312.htm EX-31.2 6347
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER dex321.htm EX-32.1 5720
  Complete submission text file 0001193125-10-184932.txt   1035278
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22873 | Film No.: 101005726
SIC: 2835 In Vitro & In Vivo Diagnostic Substances